Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-056291
Filing Date
2017-10-06
Accepted
2017-10-06 16:14:50
Documents
1
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 3506
  Complete submission text file 0001209191-17-056291.txt   5223
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address ARROWHEAD RESEARCH CORPORATION 201 SOUTH LAKE AVENUE, SUITE 703 PASADENA CA 91101
Business Address
Myszkowski Kenneth Allen (Reporting) CIK: 0001486672 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-38042 | Film No.: 171127368